(Fighting against New Coronary Pneumonia) More than 430,000 Hong Kong citizens have been vaccinated against New Coronary Pneumonia. Fubitel vaccine investigation is underway
China News Service, Hong Kong, March 27 (Reporter Zhang Xiaoxi) The Director of the Civil Service Bureau of the Special Administrative Region Government, Nie Dequan, who is responsible for coordinating the Hong Kong's new crown vaccination plan, said on the 27th that regarding the packaging of the Fubitai vaccine, he will continue to communicate with Fosun Pharma. The investigation is proceeding at full speed and will be explained to the public as soon as possible if there is any progress.
On the morning of March 22, the Chief Executive Carrie Lam Cheng Yuet-ngor of the Hong Kong Special Administrative Region and several directors of the Special Administrative Region Government received the second dose of the Coxing New Crown vaccine at the headquarters of the Special Administrative Region Government.
Photo by China News Agency reporter Li Zhihua
Since the launch of the new crown vaccination plan in Hong Kong, up to 8 pm on the 26th, a total of 435,100 citizens were vaccinated, of which about 429,500 citizens were vaccinated with the first dose, including 278,200 people vaccinated with Kexing vaccine and about 151300 people vaccinated with Fubitai vaccine .
When attending a radio program in Hong Kong on the same day, Nie Dequan said that the scope of investigation on the packaging of Fubitel vaccines will cover the production lines and packaging lines of German manufacturers, as well as the process of the supply chain after the arrival of the vaccine in Hong Kong, in order to find out the reasons.
The SAR government will continue to maintain contact with Fosun Pharma, and also requires that the investigation be completed as soon as possible.
If there are no systemic and safety issues, it will be clear when the vaccination can be resumed.
If necessary, a new batch of vaccines may be shipped from Germany to Hong Kong.
In a subsequent meeting with the media, he pointed out that the current suspension of vaccination for Fubitai in Hong Kong is a prudent measure. If there are further investigation conclusions, he will explain to the public as soon as possible.
It is hoped that before mid-April, citizens who need a second dose of Fubitai vaccine can resume vaccination.
Nie Dequan also once again called on the public to actively participate in the new crown vaccination plan.
He said that the sooner the vaccine is vaccinated, the sooner antibodies will be produced, which will benefit himself, his family and society.
(Finish)